EGFR and non-small cell lung carcinoma: The EGFR-mediated signaling pathways are essential for various biological processes including cancer development and progression, such as cell proliferation, adhesion, migration, differentiation, etc. 22-24, therefore, the EGFR tyrosine kinase has become an attractive target in cancer therapy, especially for NSCLC treatment.